Search research articles
Contact Us
Filters
Showing results (31-40 of 62) with videos related to
Page
of 7
Sort By:
Journal of Gastrointestinal Oncology
|
April 30, 2019
Increased circulating levels of vascular endothelial growth factor C can predict outcome in resectable gastric cancer patients
Angelica Petrillo, Maria Maddalena Laterza, Giuseppe Tirino, et al.
Cancers
|
July 2, 2021
Gemcitabine/Nab-Paclitaxel versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: A European Multicenter Study
Nicolas Williet, Angelica Petrillo, Gaël Roth, et al.
Future Oncology (London, England)
|
July 4, 2018
Systemic-inflammation-based score can predict prognosis in metastatic gastric cancer patients before first-line chemotherapy
Angelica Petrillo, Maria Maddalena Laterza, Giuseppe Tirino, et al.
International Journal of Molecular Sciences
|
January 8, 2023
Clinical Significance of Molecular Subtypes in Western Advanced Gastric Cancer: A Real-World Multicenter Experience
Massimiliano Salati, Michele Ghidini, Matteo Paccagnella, et al.
Therapeutic Advances in Medical Oncology
|
January 27, 2025
Rare epithelial gastric cancers: a review of the current treatment knowledge
Angelica Petrillo, Margaret Ottaviano, Luca Pompella, et al.
Journal of Clinical Medicine
|
May 15, 2019
TRPV2 Calcium Channel Gene Expression and Outcomes in Gastric Cancer Patients: A Clinically Relevant Association
Pietro Zoppoli, Giovanni Calice, Simona Laurino, et al.
Medical Oncology (Northwood, London, England)
|
August 25, 2019
Nab-paclitaxel plus gemcitabine as first line therapy in metastatic pancreatic cancer patients relapsed after gemcitabine adjuvant treatment
Angelica Petrillo, Annalisa Pappalardo, Luca Pompella, et al.
Cancer Treatment Reviews
|
February 11, 2025
How do I treat dMMR/MSI gastro-oesophageal adenocarcinoma in 2025? A position paper from the EORTC-GITCG gastro-esophageal task force
Christelle de la Fouchardière, Antonella Cammarota, Magali Svrcek, et al.
BMC Cancer
|
September 4, 2016
NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice
Ferdinando De Vita, Jole Ventriglia, Antonio Febbraro, et al.
Journal of Clinical Medicine
|
April 30, 2021
Bone Metastases from Gastric Cancer: What We Know and How to Deal with Them
Angelica Petrillo, Emilio Francesco Giunta, Annalisa Pappalardo, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 62) with videos related to
Sort By:
Page
of 7
Journal of Gastrointestinal Oncology
|
April 30, 2019
Increased circulating levels of vascular endothelial growth factor C can predict outcome in resectable gastric cancer patients
Angelica Petrillo, Maria Maddalena Laterza, Giuseppe Tirino, et al.
Cancers
|
July 2, 2021
Gemcitabine/Nab-Paclitaxel versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: A European Multicenter Study
Nicolas Williet, Angelica Petrillo, Gaël Roth, et al.
Future Oncology (London, England)
|
July 4, 2018
Systemic-inflammation-based score can predict prognosis in metastatic gastric cancer patients before first-line chemotherapy
Angelica Petrillo, Maria Maddalena Laterza, Giuseppe Tirino, et al.
International Journal of Molecular Sciences
|
January 8, 2023
Clinical Significance of Molecular Subtypes in Western Advanced Gastric Cancer: A Real-World Multicenter Experience
Massimiliano Salati, Michele Ghidini, Matteo Paccagnella, et al.
Therapeutic Advances in Medical Oncology
|
January 27, 2025
Rare epithelial gastric cancers: a review of the current treatment knowledge
Angelica Petrillo, Margaret Ottaviano, Luca Pompella, et al.
Journal of Clinical Medicine
|
May 15, 2019
TRPV2 Calcium Channel Gene Expression and Outcomes in Gastric Cancer Patients: A Clinically Relevant Association
Pietro Zoppoli, Giovanni Calice, Simona Laurino, et al.
Medical Oncology (Northwood, London, England)
|
August 25, 2019
Nab-paclitaxel plus gemcitabine as first line therapy in metastatic pancreatic cancer patients relapsed after gemcitabine adjuvant treatment
Angelica Petrillo, Annalisa Pappalardo, Luca Pompella, et al.
Cancer Treatment Reviews
|
February 11, 2025
How do I treat dMMR/MSI gastro-oesophageal adenocarcinoma in 2025? A position paper from the EORTC-GITCG gastro-esophageal task force
Christelle de la Fouchardière, Antonella Cammarota, Magali Svrcek, et al.
BMC Cancer
|
September 4, 2016
NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice
Ferdinando De Vita, Jole Ventriglia, Antonio Febbraro, et al.
Journal of Clinical Medicine
|
April 30, 2021
Bone Metastases from Gastric Cancer: What We Know and How to Deal with Them
Angelica Petrillo, Emilio Francesco Giunta, Annalisa Pappalardo, et al.
Page
of 7